Fact CheckerSign in

NCT05858255Recruiting

Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study

Source: ClinicalTrials.gov · Last updated 15 May 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical intervention study is to investigate the effects of exergaming on cognition and other clinical symptoms in outpatient individuals with schizophrenia. The main questions it aims to answer are: Will an exergaming intervention contribute to improved cognition and reduced clinical symptoms, as well as enhanced physical health/self-efficacy/quality of life, in individuals with schizophrenia? Will the gaming component strengthen motivation for a physically more intensive component, so that attendance will be at least as high as in comparable exercise studies despite the current study being implemented in a resource-limited, regular clinical outpatient setting? Participants will be asked to engage in two 45 minutes exergaming sessions with a designated personal trainer for 12 weeks. Results pre- and post intervention will be compared, and comparisons will also be made with a former randomized controlled trial conducted at the same site, in which the currently combined activities were investigated separately (high-intensity interval training and low-intensity video gaming), both yielding positive but different effects.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
48 (estimated)
First submitted
18 Apr 2023
Start date
29 Mar 2023
Primary completion date
31 Dec 2025
Lead sponsor
Sykehuset i Vestfold HF
NCT number
NCT05858255

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 29 Mar 2023 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of neurological disorder
  • History of severe head trauma
  • Unstable angina pectoris
  • Malignant hypertension
  • Uncontrollable arrhythmia
  • Recent myocardial infarction
  • Acute infection with lymphadenopathy
  • Other specified medical condition incompatible with participation

Other

  • Diagnosis of intellectual disability
  • Pregnancy
  • Chest pain during exercise

Who the study is looking for

  • Having consent capability
  • Understanding and speaking Scandinavian language
  • Fulfilling the International Classification of Diseases Tenth Revision (ICD 10) criteria for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder and schizophreniform disorder)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
DPS Vestfold, Vestfold Sykehus HF
Coordinator of this site? Confirm its status
TønsbergNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.